Context Therapeutics Ownership | Who Owns Context Therapeutics?
Context Therapeutics Ownership Summary
Context Therapeutics is owned by 4.37% institutional investors, 1.18% insiders, and 94.45% retail investors. Bioimpact capital is the largest institutional shareholder, holding 11.62% of CNTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.48% of its assets in Context Therapeutics shares.
CNTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Context Therapeutics | 4.37% | 1.18% | 94.45% |
| Sector | Healthcare Stocks | 35.34% | 11.88% | 52.77% |
| Industry | Biotech Stocks | 35.37% | 11.83% | 52.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bioimpact capital | 10.68M | 11.62% | $27.98M |
| Nextech invest | 7.42M | 9.22% | $7.79M |
| Deep track capital, lp | 7.42M | 8.08% | $19.44M |
| Nextech invest | 7.42M | 8.08% | $19.44M |
| Soleus capital management | 6.96M | 7.58% | $18.24M |
| Octagon capital advisors lp | 5.25M | 5.71% | $13.76M |
| Blue owl capital lp | 5.09M | 5.54% | $13.33M |
| Avidity partners management lp | 5.00M | 5.44% | $11.80M |
| Blackrock | 851.70K | 5.33% | $1.71M |
| Franklin resources | 3.80M | 4.14% | $9.96M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Blue owl capital lp | 5.09M | 3.58% | $13.33M |
| Avidity partners management lp | 5.00M | 2.67% | $11.80M |
| Bioimpact capital | 10.68M | 2.16% | $27.98M |
| Octagon capital advisors lp | 5.25M | 1.52% | $13.76M |
| Nextech invest | 7.42M | 1.37% | $19.44M |
| Great point partners | 2.24M | 1.35% | $5.86M |
| Nextech invest | 7.42M | 1.26% | $7.79M |
| Soleus capital management | 6.96M | 0.74% | $18.24M |
| Sio capital management | 917.92K | 0.34% | $2.40M |
| Deep track capital, lp | 7.42M | 0.32% | $19.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 6.96M | 0.74% | 6.96M |
| Octagon capital advisors lp | 5.25M | 1.52% | 5.25M |
| Tcg crossover management | 2.68M | 0.20% | 2.68M |
| Susquehanna group, llp | 1.09M | 0.00% | 1.09M |
| Adage capital partners gp | 1.00M | 0.00% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Great point partners | 2.24M | 1.35% | -2.45M |
| Blackstone | - | - | -2.44M |
| Blue owl capital lp | 5.09M | 3.58% | -2.34M |
| Driehaus capital management | - | - | -2.26M |
| Alyeska investment group | - | - | -1.66M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Soleus capital management | 6.96M | 0.74% | 6.96M | $18.24M |
| Octagon capital advisors lp | 5.25M | 1.52% | 5.25M | $13.76M |
| Tcg crossover management | 2.68M | 0.20% | 2.68M | $7.03M |
| Adage capital partners gp | 1.00M | 0.00% | 1.00M | $2.62M |
| Blackrock | 851.70K | - | 851.70K | $1.71M |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -116.00 |
| Barclays | -167.00 |
| Advisornet financial | -200.00 |
| Federation des caisses desjardins du quebec | -400.00 |
| Newbridge financial services group | -2.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 12 | -71.43% | 4,160,373 | -93.62% | 4 | 0.09% | 8 | -52.94% | 1 | -87.50% |
| Dec 31, 2025 | 10 | -72.97% | 16,071,417 | -76.70% | 16 | 0.32% | 3 | -75.00% | 3 | -57.14% |
| Sep 30, 2025 | 5 | -87.18% | 3,733,804 | -94.56% | 3 | 0.08% | 3 | -76.92% | - | -100.00% |
| Jun 30, 2025 | 39 | -9.30% | 68,619,080 | -3.91% | 72 | 1.28% | 12 | 20.00% | 9 | -35.71% |
| Mar 31, 2025 | 9 | -82.69% | 31,512,715 | -56.71% | 33 | 0.40% | - | -100.00% | 1 | -91.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 3.12M | 3.48% | -6.75K |
| Vanguard Total Stock Mkt Idx Inv | 2.82M | 3.06% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.40M | 2.62% | - |
| Franklin Biotechnology Discovery A | 1.40M | 1.52% | -80.37K |
| Vanguard Institutional Extnd Mkt Idx Tr | 520.90K | 0.57% | - |
| Calamos Market Neutral Income A | 277.81K | 0.30% | - |
| Fidelity Extended Market Index | 260.31K | 0.28% | 12.57K |
| Belfund SICAV Belinvest Equity A USD Acc | 260.00K | 0.28% | - |
| BlackRock Extended Equity Market K | 104.84K | 0.14% | -45.00 |
| Blackrock Extended Mkt Fund CF | 120.30K | 0.13% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 09, 2025 | Lehr Martin A. | Chief Executive Officer | Buy | $70.08K |
| Jun 06, 2025 | Levit Alex C. | Chief Legal Officer, Corp. Sec | Buy | $11.52K |
| Jun 06, 2025 | Minai-Azary Jennifer Lynn | Chief Financial Officer | Buy | $25.49K |
| Feb 21, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
| Feb 13, 2023 | Lehr Martin A. | Chief Executive Officer | Buy | $4.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 3 | - |
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
CNTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools